Tamara Friedman, E. G. Paleoudis, Avery Freed, Susan Adler, Cheryl Fittizzi
{"title":"How a Network Came Together to Manage a Large Research Program During the Pandemic","authors":"Tamara Friedman, E. G. Paleoudis, Avery Freed, Susan Adler, Cheryl Fittizzi","doi":"10.17140/ctpoj-3-114","DOIUrl":null,"url":null,"abstract":"Hackensack Meridian Health, a large New Jersey network comprised of 17 hospitals, a medical school, and 200 ambulatory care centers, executes a large research program with approximately 1000 active human subjects studies. With the arrival of the coronavirus disease-2019 (COVID-19) pandemic, the Office of Research Administration was confronted with a series of challenges. These included minimizing face-to-face contact among research participants and staff, allocating limited resources to handle the influx of COVID-19 related proposals, providing human subjects protection training to the physicians and staff who were needed to run the clinical trials, adjusting bio-repository activities to meet the increased demand for samples, and disseminating all of the new regulatory and operational information to the thousands of researchers in the network. The network’s success in modifying its research program quickly and effectively to adapt to the changing landscape can be attributed, in large part, to the centralized nature of the research administration.","PeriodicalId":259842,"journal":{"name":"Clinical Trials and Practice – Open Journal","volume":"110 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Trials and Practice – Open Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17140/ctpoj-3-114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Hackensack Meridian Health, a large New Jersey network comprised of 17 hospitals, a medical school, and 200 ambulatory care centers, executes a large research program with approximately 1000 active human subjects studies. With the arrival of the coronavirus disease-2019 (COVID-19) pandemic, the Office of Research Administration was confronted with a series of challenges. These included minimizing face-to-face contact among research participants and staff, allocating limited resources to handle the influx of COVID-19 related proposals, providing human subjects protection training to the physicians and staff who were needed to run the clinical trials, adjusting bio-repository activities to meet the increased demand for samples, and disseminating all of the new regulatory and operational information to the thousands of researchers in the network. The network’s success in modifying its research program quickly and effectively to adapt to the changing landscape can be attributed, in large part, to the centralized nature of the research administration.
Hackensack Meridian Health是新泽西州一个由17家医院、一所医学院和200个流动护理中心组成的大型网络,它执行了一个大型研究项目,其中包括大约1000个活跃的人类受试者研究。随着2019冠状病毒病(COVID-19)大流行的到来,研究行政办公室面临着一系列挑战。这些措施包括尽量减少研究参与者和工作人员之间的面对面接触,分配有限的资源来处理大量涌入的与COVID-19相关的提案,为开展临床试验所需的医生和工作人员提供人类受试者保护培训,调整生物库活动以满足不断增长的样本需求,以及向网络中的数千名研究人员传播所有新的监管和操作信息。该网络在快速有效地修改其研究计划以适应不断变化的环境方面的成功,在很大程度上可归因于研究管理的集中性质。